175 related articles for article (PubMed ID: 21154136)
21. HDAC Inhibitors--CHI's Third Annual Conference.
Rosato RR
IDrugs; 2010 Jan; 13(1):13-5. PubMed ID: 20024840
[TBL] [Abstract][Full Text] [Related]
22. New Clinical Trial Designs Hasten Approvals for Targeted Therapies.
Schmidt C
J Natl Cancer Inst; 2016 Mar; 108(3):. PubMed ID: 26944760
[No Abstract] [Full Text] [Related]
23. Pharmacokinetics, clinical indications, and resistance mechanisms in molecular targeted therapies in cancer.
Izar B; Rotow J; Gainor J; Clark J; Chabner B
Pharmacol Rev; 2013; 65(4):1351-95. PubMed ID: 24092887
[TBL] [Abstract][Full Text] [Related]
24. Oncogenic targets, magnitude of benefit, and market pricing of antineoplastic drugs.
Amir E; Seruga B; Martinez-Lopez J; Kwong R; Pandiella A; Tannock IF; Ocaña A
J Clin Oncol; 2011 Jun; 29(18):2543-9. PubMed ID: 21606435
[TBL] [Abstract][Full Text] [Related]
25. American association for cancer research - 101st annual meeting - investigating new therapeutic candidates: part 1.
Mason VL
IDrugs; 2010 Jun; 13(6):357-9. PubMed ID: 20506052
[TBL] [Abstract][Full Text] [Related]
26. Ubiquitin Drug Discovery & Diagnostics 2009 - First Annual Conference.
Marblestone JG
IDrugs; 2009 Dec; 12(12):750-3. PubMed ID: 19943215
[TBL] [Abstract][Full Text] [Related]
27. AACR-NCI-EORTC--21st International Symposium. Molecular targets and cancer therapeutics--Part 1.
Walker K; Padhiar M
IDrugs; 2010 Jan; 13(1):7-9. PubMed ID: 20024838
[TBL] [Abstract][Full Text] [Related]
28. Dose determination for molecularly targeted therapies: Much Ado About Nothing.
Tolcher A
Cancer; 2017 Apr; 123(8):1298-1300. PubMed ID: 28182254
[No Abstract] [Full Text] [Related]
29. Medichem--BIT Life Sciences' First Annual International Conference.
Corson TW
IDrugs; 2010 Jul; 13(7):453-6. PubMed ID: 20582869
[TBL] [Abstract][Full Text] [Related]
30. AACR meeting highlights new findings on drug resistance, targeted therapies.
Printz C
Cancer; 2013 Sep; 119(18):3259. PubMed ID: 24037707
[No Abstract] [Full Text] [Related]
31. Pharmaceutical Pricing and Market Access Outlook Europe 2010-HealthNetwork Communications' fourth annual conference. 24-25 March 2010, London, UK.
Ogbighele E
IDrugs; 2010 May; 13(5):317-20. PubMed ID: 20432188
[TBL] [Abstract][Full Text] [Related]
32. AIMECS 09--Seventh AFMC International Medicinal Chemistry Congress. 23-27 August 2009, Cairns, Queensland, Australia.
Chan D
IDrugs; 2009 Oct; 12(10):614-6. PubMed ID: 19790007
[TBL] [Abstract][Full Text] [Related]
33. Bangalore India Bio 2010.
Thammanabhatla P; Pailla M
IDrugs; 2010 Aug; 13(8):527-9. PubMed ID: 20721821
[TBL] [Abstract][Full Text] [Related]
34. International Society for Eye Research--XIXth Biennial Meeting.
Pfeffer U
IDrugs; 2010 Sep; 13(9):619-21. PubMed ID: 20799143
[TBL] [Abstract][Full Text] [Related]
35. Metastasis and the Tumor Microenvironment: A Joint Metastasis Research Society-AACR Conference - Research on Metastasis: Part 1.
Eccles SA
IDrugs; 2010 Nov; 13(11):765-7. PubMed ID: 21046522
[TBL] [Abstract][Full Text] [Related]
36. Metastasis and the Tumor Microenvironment: A Joint Metastasis Research Society-AACR Conference - Research on Metastasis: part 2.
Eccles SA
IDrugs; 2010 Nov; 13(11):768-71. PubMed ID: 21046523
[TBL] [Abstract][Full Text] [Related]
37. New developments on targeted cancer therapy: Multi-faceted issues in targeted cancer therapy.
Bao J; Qiao L
Cancer Lett; 2017 Feb; 387():1-2. PubMed ID: 28038727
[No Abstract] [Full Text] [Related]
38. AACR-NCI-EORTC--21st International Symposium. Molecular targets and cancer therapeutics--Part 2.
Walker K; Padhiar M
IDrugs; 2010 Jan; 13(1):10-2. PubMed ID: 20024839
[TBL] [Abstract][Full Text] [Related]
39. The 11th International Congress on Targeted Anticancer Therapies Paris, 4-6 March 2013 (TAT 2013).
Samoilenko O; Zaletok S
Exp Oncol; 2013 Sep; 35(3):231-5. PubMed ID: 24084465
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
